Applicant, as named in the Orange Book

Alnylam Pharms Inc

Next listed expiry: Givlaari on 3 Oct 2034. 4 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Givlaari NDA 212194 givosiran sodium	givosiran sodium	3 Oct 2034 patent	patent
Onpattro NDA 210922 patisiran sodium	patisiran sodium	27 Aug 2035 patent	patent
Amvuttra NDA 215515 vutrisiran sodium	vutrisiran sodium	28 Jul 2036 patent	patent
Oxlumo NDA 214103 lumasiran sodium	lumasiran sodium	29 May 2041 patent	patent

Givlaari · Exclusivity expires within 90 days ODE-273Exclusivity expires 20 Nov 2026Detected 24 Oct 2026